The Novartis Venture Fund was created to foster innovation, drive significant patient benefit, and generate superior returns by nurturing and investing in innovative life science companies. The fund invests in various biotechnology and biopharmaceuticals at different stages of growth and development.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions